top of page

PORTFOLIO

CBI has successfully created a diversified portfolio of biotechnology and medical technology companies, that develop proprietary solutions for unmet medical needs. These companies draw on cutting-edge research from leading institutions and top minds in Israel and the United States. CBI and its portfolio companies actively collaborate with multinational pharmaceutical corporations and prominent investment funds, fostering strategic partnerships to drive growth and innovation.

Biotechnology Companies

Mediwouund logo

MediWound
(NASDAQ:MDWD)

Enzymatic therapeutics for tissue repair
 

Biokine logo

Biokine 
 

Stem cells mobilization in cancer
 

Elicio therapeutics logo

Elicio Therapeutics
(NASDAQ:ELTX)

Cancer immunotherapy 

 

Cadent Therapeutics logo

Cadent Therapeutics
(Acq. Novartis)

CNS disorders

 

Anatomy medical technology fund logo
Sight diagnostics logo

Sight Diagnostics
 

Point of care Blood diagnostics
 

Colospan logo

Colospan
 

Novel solutions for colorectal surgery

Pi-Cardia logo

Pi-Cardia
 

Non-implant heart valve repair solutions

Fdna logo

FDNA
 

AI-powered diagnostics for genetic disorders

bottom of page